Phase I-II study of intravenous BCX-1777 [forodesine] in relapsed or refractory aggressive (high grade) T-cell malignancies
Phase of Trial: Phase I/II
Latest Information Update: 12 Jan 2006
At a glance
- Drugs Forodesine (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2005 New trial record.